In Massachusetts we have had more signs of the pivoting underway in the advanced bioeconomy with the news that Metabolix is changing its name to Yield10 Bioscience and will focus on developing disruptive technologies for step-change improvements to crop yield to enhance global food security. The company is hard at work re-thinking how it talks […]
In Massachusetts, we reported this week that Metabolix is changing its name to Yield10 Bioscience and will focus on developing disruptive technologies for step-change improvements to crop yield to enhance global food security. Here’s the investor presentation given last October, explaining the background and the rationale.
In Massachusetts, Metabolix has signed a Memorandum of Understanding (MOU) to produce specialty PHAs with CJ CheilJedang Corporation at a 10 kiloton PHA production unit at CJ’s Fort Dodge, Iowa facility. Under the agreement, Metabolix will buy the speciality PHAs, including its recently launched amorphous PHA, which can be used as a multifunctional additive, and […]
In Massachusetts, Metabolix announced that Joseph Shaulson will become president and CEO effective January 2, 2014 and as a member of the Board of Directors, effective immediately. Shaulson, previously Executive Vice President of Arch Chemicals, will succeed Richard Eno, who will remain with the Company until January 31, 2014 to assist with the transition. Metabolix also […]
In Massachusetts, Metabolix launched Mvera B5011, a new film grade resin that allows for production of compostable, and highly transparent, film and bags. Metabolix designed Mvera B5011 to meet international industrial standards for compostability, while also enabling customers to produce films for compostable bags and packaging applications with exceptional transparency compared to competing products. B5011 […]
In Massachusetts, Metabolix announced its Chief Scientific Officer Oliver Peoples, Ph.D. will present the Company’s strategy for its polyhydroxyalkanoate (PHA)-based biopolymers and biobased chemicals platform. This presentation will include new data on the successful conversion of second generation cellulosic sugars to PHA precursors for the production of PHA biopolymers and biobased chemicals, including C3 (bio-acrylic) […]
In Massachusetts, Metabolix reported a net loss of $7.3 million, or $0.21 per share, for the third quarter of 2013, as compared to a net loss of $7.7 million, or $0.23 per share, for the third quarter of 2012. Revenue for the nine months ended September 30, 2013 was $4.5 million, compared to $40.9 million […]
In Seeking Alpha, the guide warns against investing in Metabolix for all but the most risk-tolerant investors. Claiming that the company is struggling to develop new sources of revenue, with a shrinking cash reserve and no financing for a new commercial-scale facility after the termination of its joint venture with DSM. The article also cites […]
In Massachusetts, Metabolix announced Mvera B5010, a new compostable film grade resin. Mvera B5010 film grade resin is designed for the compostable bag and film markets. Metabolix developed Mvera B5010 film grade resin to meet international industrial standards for compostability, and has been certified by Vinçotte to meet the EN13432 standard. Mvera B5010 resin allows […]
In Massachusetts, Metabolix reported it has formed a collaboration with Samsung Fine Chemicals. Mr. Eno, Metabolix President and CEO stated, “This quarter, we are pleased to have formalized a collaboration with Samsung Fine Chemicals to focus on expanding the global market for biodegradable polymers. New products we develop through this relationship are expected to benefit […]
